Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
XERIS PHARMACEUTICALS INC (XERS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2021 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 19,650 options to buy
@ $12.5, valued at
$245.6k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 19,650 options to buy
@ $12.5, valued at
$245.6k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 5,659 shares
@ $0
Disposed/sold 25,220 options to buy
@ $12.5, valued at
$315.3k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 19,650 options to buy
@ $12.5, valued at
$245.6k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| Edick Paul R (CEO) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 197,231 shares
@ $0
Disposed/sold 410,833 shares
@ $0
Disposed/sold 13,430 shares
@ $0
Disposed/sold 668,065 options to buy
@ $1.55, valued at
$1M
Disposed/sold 69,822 options to buy
@ $1.55, valued at
$108.2k
Disposed/sold 98,252 options to buy
@ $5.93, valued at
$582.6k
Disposed/sold 200,000 options to buy
@ $13.88, valued at
$2.8M
Disposed/sold 400,000 options to buy
@ $5.08, valued at
$2M
|
|
| 10/05/2021 |
4
| Pieper Steven (CFO) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 23,775 shares
@ $0
Disposed/sold 134,333 shares
@ $0
Disposed/sold 16,843 options to buy
@ $1.55, valued at
$26.1k
Disposed/sold 2,640 options to buy
@ $1.55, valued at
$4.1k
Disposed/sold 14,036 options to buy
@ $5.93, valued at
$83.2k
Disposed/sold 12,500 options to buy
@ $6.37, valued at
$79.6k
Disposed/sold 27,891 options to buy
@ $4.09, valued at
$114.1k
|
|
| 10/05/2021 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 384,780 shares
@ $0
Disposed/sold 110,000 shares
@ $0
Disposed/sold 11,228 options to buy
@ $0.69, valued at
$7.7k
Disposed/sold 28,072 options to buy
@ $1.55, valued at
$43.5k
Disposed/sold 11,266 options to buy
@ $1.55, valued at
$17.5k
Disposed/sold 14,036 options to buy
@ $5.93, valued at
$83.2k
Disposed/sold 25,000 options to buy
@ $13.88, valued at
$347k
Disposed/sold 25,000 options to buy
@ $3.94, valued at
$98.5k
|
|
| 10/05/2021 |
4
| Hecht Beth (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 26,366 shares
@ $0
Disposed/sold 180,000 shares
@ $0
Disposed/sold 30,879 options to buy
@ $5.93, valued at
$183.1k
Disposed/sold 65,295 options to buy
@ $12.5, valued at
$816.2k
Disposed/sold 3,826 options to buy
@ $19, valued at
$72.7k
Disposed/sold 32,500 options to buy
@ $13.88, valued at
$451.1k
Disposed/sold 150,000 options to buy
@ $3.94, valued at
$591k
|
|
| 10/05/2021 |
4
| JOHNSON KENNETH ERLAND (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 11,250 shares
@ $0
Disposed/sold 78,333 shares
@ $0
Disposed/sold 33,686 options to buy
@ $1.55, valued at
$52.2k
Disposed/sold 5,280 options to buy
@ $1.55, valued at
$8.2k
Disposed/sold 39,633 options to buy
@ $5.93, valued at
$235k
Disposed/sold 21,401 options to buy
@ $19, valued at
$406.6k
Disposed/sold 32,500 options to buy
@ $13.88, valued at
$451.1k
Disposed/sold 100,000 options to buy
@ $3.94, valued at
$394k
|
|
| 10/05/2021 |
4
| PERSKY MARLA (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 19,650 options to buy
@ $12.5, valued at
$245.6k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| Shannon John Patrick Jr (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 70,496 shares
@ $0
Disposed/sold 193,333 shares
@ $0
Disposed/sold 160,335 options to buy
@ $1.55, valued at
$248.5k
Disposed/sold 25,136 options to buy
@ $1.55, valued at
$39k
Disposed/sold 28,072 options to buy
@ $5.93, valued at
$166.5k
Disposed/sold 34,977 options to buy
@ $12.5, valued at
$437.2k
Disposed/sold 80,000 options to buy
@ $13.88, valued at
$1.1M
Disposed/sold 100,000 options to buy
@ $3.94, valued at
$394k
|
|
| 07/29/2021 |
4
| Pieper Steven (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 07/29/2021 |
3
| Pieper Steven (See Remarks) has filed a Form 3 on XERIS PHARMACEUTICALS INC |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 04/13/2021 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $4.0725, valued at
$40.7k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Hecht Beth (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $6.0058, valued at
$60.1k
|
|
| 01/12/2021 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $5.7244, valued at
$57.2k
|
|
| 12/17/2020 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 12/10/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 10,000 shares
@ $4.0551, valued at
$40.6k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|